Trump’s Iran Strike: Pharma-Biotech Armageddon
A U.S. military strike on Iran under President Donald Trump in early 2026 would trigger a hybrid retaliation that strikes at the heart of America’s pharmaceutical and biotechnology supremacy. Tehran’s response would blend conventional threats with sophisticated cyber operations, proxy actions, and disinformation campaigns specifically calibrated to cripple U.S. pharma and biotech sectors. Iranian state-linked…
